CogEval
By Biogen
CogEval is an iPad-based cognitive assessment tool for healthcare providers managing multiple sclerosis patients.
The App DNA
What makes this app unique?
It replaces manual, paper-based cognitive testing with a validated, two-minute digital assessment that eliminates data storage liability for clinics.
For Healthcare professionals responsible for the management of patients with multiple sclerosis.
Key features
Two-minute cognitive assessment measuring attention, psychomotor speed, visual processing, and working memory.
Assessment methodology validated against the Symbol Digit Modalities Test, providing clinical authority.
Automatic reset of patient information after each use, removing data storage liability.
How much does it cost?
The app functions as a free clinical utility, likely serving as a professional support tool for the developer's medical portfolio.
Velocity
Dormant developmentopaqueShow more...
CogEval has seen no development activity for 297 days, placing it firmly in the zombie category. The single release within the analyzed window provided only generic stability improvements, and there have been no subsequent updates or feature additions. The lack of activity over the past nine months suggests the project is no longer receiving active maintenance or support.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for CogEval
How's the Health & Fitness market?
CogEval maintains a specialized position as a free clinical utility on the App Store with a 5.0-star rating. Its focus on MS-specific cognitive assessment distinguishes it from broader health apps, though the lack of recent updates limits its competitive agility.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for CogEval
Where is it heading?
The market for specialized clinical assessment tools remains stable, with providers prioritizing validation and compliance over feature-heavy interfaces. CogEval is well-positioned as a niche utility, but its long-term relevance depends on whether it evolves to support longitudinal patient data.
- The nine-month release silence indicates CogEval is in maintenance mode, serving as a static support tool rather than an active growth product.
- Clinical validation against the SDMT standard ensures CogEval remains a trusted, compliant utility for healthcare providers in the MS space.
The SWOT
- Clinical validation against SDMT standard
- Zero-data persistence removes storage liability
- Secure cloud-sync for longitudinal tracking
Next best moves
Audit clinical demand for longitudinal tracking because the current zero-data model prevents patient progress monitoring → unlock higher clinical utility
The counter-intuitive read
The app's lack of data persistence is marketed as a privacy strength…
Read the full takeBottom line
CogEval provides a validated, privacy-compliant assessment for MS management, but the lack of longitudinal tracking limits its long-term clinical value. Adding secure, compliant data storage would unlock significant utility for providers who currently rely on manual tracking.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated